A Study to Evaluate the Safety and Pharmacokinetics of NTM-1633 vs Placebo Administered Intravenously in Healthy Adults
Clinical trial NCT03603665 · COMPLETED
Trial details
- NCT number
- NCT03603665
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-25
- Primary completion
- 2019-06-11
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.